BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20659094)

  • 1. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.
    Collett D; Mumford L; Banner NR; Neuberger J; Watson C
    Am J Transplant; 2010 Aug; 10(8):1889-96. PubMed ID: 20659094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
    Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
    Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
    Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
    Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
    Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
    Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
    Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
    Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
    Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study.
    Naldi L; Fortina AB; Lovati S; Barba A; Gotti E; Tessari G; Schena D; Diociaiuti A; Nanni G; La Parola IL; Masini C; Piaserico S; Peserico A; Cainelli T; Remuzzi G
    Transplantation; 2000 Nov; 70(10):1479-84. PubMed ID: 11118094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
    Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
    Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease.
    Otley CC; Cherikh WS; Salasche SJ; McBride MA; Christenson LJ; Kauffman HM
    J Am Acad Dermatol; 2005 Nov; 53(5):783-90. PubMed ID: 16243126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.
    Sexton DJ; O'Kelly P; O'Leary E; Murray S; Deady S; Daly F; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Moloney FJ; O'Neill JP; Conlon PJ
    JAMA Dermatol; 2019 May; 155(5):594-598. PubMed ID: 30725084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National survey of de novo malignancy after solid organ transplantation in Japan.
    Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
    Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation.
    Bennett LE; Keck BM; Daily OP; Novick RJ; Hosenpud JD
    Clin Transpl; 2000; ():31-44. PubMed ID: 11512324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group.
    O'Neill JP; Sexton DJ; O'Leary E; O'Kelly P; Murray S; Deady S; Daly F; Williams Y; Dean B; Fitzgerald C; Murad A; Mansoor N; O'Neill JO; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Little D; Moloney FJ; Conlon PJ
    Clin Transplant; 2019 Oct; 33(10):e13669. PubMed ID: 31310037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
    Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
    Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    Lee KF; Tsai YT; Lin CY; Hsieh CB; Wu ST; Ke HY; Lin YC; Lin FY; Lee WH; Tsai CS
    PLoS One; 2016; 11(5):e0155602. PubMed ID: 27196400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.